Clinical trial Recruiting at 1 site Interventional Ages 21 and up

Quantum Molecular Resonance to Treat Neuropathic Corneal Pain and Regrow Corneal Nerves

Official title: Efficacy of Quantum Molecular Resonance in Neuropathic Corneal Pain and Corneal Nerve Regeneration

Run by Singapore Eye Research Institute · NCT07174739 · Data updated 2026-11-12

This study will try Quantum Molecular Resonance (QMR) to reduce eye pain and promote corneal nerve regrowth in adults with neuropathic corneal pain.

Quick facts

Study typeInterventional
Ages21 Years and up
SexAll
Enrollment30 (estimated)
SponsorSingapore Eye Research Institute
Academic / other
Drugs / interventionsradiation
Locations1 site (Singapore)
StatusRecruiting
StartedNovember 1, 2023
Main results expectedOctober 31, 2026
Study endsDecember 31, 2026
Registry record updatedSeptember 19, 2025
Trial IDNCT07174739 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 21 and older with diagnosed neuropathic corneal pain, minimal slit-lamp findings, and corneal nerve abnormalities on IVCM who can attend all study visits are ideal candidates.

Probably not a fit

Patients who are pregnant, have active implantable electronic devices, recent ocular surgery, active ocular infection or inflammation, or are undergoing cancer treatment are excluded and unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with neuropathic corneal pain will attend nine visits including one baseline assessment and eight QMR treatment sessions using a Rexon-Eye device. At each visit participants will undergo ocular surface exams, in vivo confocal microscopy to measure corneal nerve morphology, tear protein collection, and symptom and quality-of-life questionnaires. Investigators will compare pain scores, corneal nerve metrics, ocular surface findings, and tear biomarkers before and after the QMR treatment course. The study team hypothesizes that repeated QMR sessions will reduce pain, stimulate corneal nerve regeneration, and improve patient-reported quality of life.

Why it matters

Potential benefit: If successful, QMR could reduce chronic eye pain, improve corneal nerve structure, and enhance daily functioning and quality of life for affected patients.

How similar studies have gone: Small studies of QMR/Rexon-Eye in dry eye populations have reported symptom improvements, but rigorous evidence for use in neuropathic corneal pain is limited and relatively untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Be at least 21 years of age.
* Regardless of gender (Male/Female).
* Regardless of race (Chinese/Malay/Indian/Eurasian/Others).
* Diagnosed with neuropathic corneal pain based on the following criteria: presence of neuropathic ocular symptoms (burning, stinging, photophobia, pain, severe dryness), absent or minimal slit-lamp findings to explain the symptoms and corneal nerve abnormalities as detected by IVCM (decreased corneal length and density, presence of neuromas).
* Willing to receive all eye examinations in this study.

Exclusion Criteria:

* Pregnant women.
* Participants carrying active implantable devices (e.g., pacemakers and hearing aids).
* Oncologic patients under treatment; patient who underwent ocular surgery in the last month.
* Participants who had ocular infection within 6 months, or active ocular infection or inflammation; any concomitant ocular diseases that could potentially induce ocular pain, such as uveitis.

Where it's running

  • Singapore National Eye Centre
    Singapore, Singapore
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.